Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam vs Pentobarbital for GHB Withdrawal
NCT00123578Phase 2Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2004
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lorazepam in gamma-hydroxybutyrate withdrawal (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Clinical Institute Withdrawal Assessment scale. Planned start Aug 2004; status: withdrawn.
02
Drugs
lorazepam
03
Conditions
gamma-hydroxybutyrate withdrawal
Beyond the preview
Go deeper on NCT00123578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123578.